Human cancer inhibitory peptide amides
AssigneeArizona Board of Regents acting on behalf of Arizona State University
InventorsGeorge R. Pettit, Jayaram K. Srirangam, Michael D. Williams
Life of this patent
Estimating the term…
Abstract
This application discloses seven newly synthesized pentapeptide amides and our tetrapeptide amides. The synthesis utilized both naturally occurring and modified amino acids; the modified amino acids are constituents of the well known dolastatin 10 and dolastatin 15 which are structurally distinct peptides with excellent antineoplastic activity. These peptides were constructed by introducing a peptide bond between selected amino acids and modified amino acids and coupling the resulting di- and tri-peptides to obtain peptides having a high anticancer activity against a series of human cancer cell lines. ##STR1##
Claims5
A compound having the general structure below:
- ##STR4## wherein R is selected from the group consisting of:
- Doe "10a";
- NH-2ClPEA "10b";
- NH-3ClPEA, "10c";
- and NH-4ClPEA, "10d".
Dependencies are inferred from the claim text.